This L.A. Start-Up Is Building Tiny Injectable Robots to Attack Tumors
5th March 2021
Backed by $20 million in venture capital funding and building off recent advances in robotics and precision manufacturing, the Culver City company is developing a device the size of a breadcrumb that doctors can insert into the spine or skull and magnetically steer to a target to deliver a precise dose of drugs. The plan is to move to clinical trials by 2023.